Puma Biotechnology, Inc.
PBYI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401667
In the last 90 days, Puma Biotechnology, Inc. insiders filed 0 open-market purchases and 5 sales; 160 institutions reported holding it in 13F filings for Q2 2026, worth $313.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Puma Biotechnology, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 68 | 69 | +1 |
| Shares | 26.6M | 25.7M | −871.5K (−3.3%) |
| Value | $93.8M | $67.6M | −$26.2M (−27.9%) |
New holders (6)
Institutions that held Puma Biotechnology, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citigroup Inc | 99,767 | $262.4K | 0.00% |
| Virtu Financial LLC | 14,262 | $38.0K | 0.00% |
| Qube Research & Technologies Ltd | 8,350 | $22.0K | 0.00% |
| Headlands Technologies LLC | 192 | $505 | 0.00% |
| JNBA Financial Advisors | 4 | $11 | 0.00% |
| ZRC Wealth Management, LLC | 3 | $8 | 0.00% |
Sold out (5)
Institutions that held Puma Biotechnology, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Cornercap Investment Counsel Inc | 126,963 | $448.2K |
| PDT Partners, LLC | 21,946 | $77.5K |
| Caxton Associates LP | 16,247 | $57.4K |
| Impact Partnership Wealth, LLC | 308 | $1.09K |
| Tucker Asset Management LLC | 126 | $445 |